MY109207A - Subcutaneous implants based on nomegestrol derivatives - Google Patents

Subcutaneous implants based on nomegestrol derivatives

Info

Publication number
MY109207A
MY109207A MYPI93002555A MYPI19932555A MY109207A MY 109207 A MY109207 A MY 109207A MY PI93002555 A MYPI93002555 A MY PI93002555A MY PI19932555 A MYPI19932555 A MY PI19932555A MY 109207 A MY109207 A MY 109207A
Authority
MY
Malaysia
Prior art keywords
implants
alpha
nomegestrol
derivatives
efficient
Prior art date
Application number
MYPI93002555A
Inventor
Paris Jacques Monsieur
Elsimer Coutinho Monsieur
Lanquetin Michel Monsieur
Thomas Jean Louis Monsieur
Original Assignee
Laboratoire Theramex Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex Sa filed Critical Laboratoire Theramex Sa
Priority to MYPI93002555A priority Critical patent/MY109207A/en
Publication of MY109207A publication Critical patent/MY109207A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

THIS PATENT APPLICATION RELATES TO THE FIELD OF MEDICINAL CHEMISTRY AND MORE PARTICULARLY, TO THAT OF PHARMACOTECHNOLOGY. IT HAS MORE PARTICULARLY AS A SUBJECT MATTER NOVEL COMPOSITIONS ADAPTED TO THE LOCAL WAY AND MORE PRECISELY TO FORMULATIONS INTENDED TO BE INSERTED INTO THE SUBCUTANEOUS TISSUES AND COMMONLY SO-CALLED IMPLANTS. THESE IMPLANTS ARE OF VARIOUS NATURES (HYDROPHOBIC, HYDROPHILIC, BIODEGRADABLE) AND OF VARIOUS KINDS (CONTAINER, MATRIX). THESE IMPLANTS INCLUDE AN EFFICIENT AMOUNT OF A 3,20-DIOXO 6-METHYL 17(ALPHA)-ACETOXY 19-NOR PREGNA 4,6-DIEN DERIVATIVE OPTIONALLY SUBSTITUTED IN POSITION 3 AND/OR IN POSITION 17 (ALPHA) , IN ADMIXTURE OR CONJUNCTION WITH AN INERT BIOLOGICALLY -ACCEPTABLE CARRIER. THE THUS, PRODUCED IMPLANTS ARE EFFICIENT CONTRACEPTIVE AGENTS AND HAVING A DURATION OF ACTIVITY OF AT LEAST ONE YEAR WITH THE MINIMUM OF SIDE-EFFECTS.
MYPI93002555A 1993-12-02 1993-12-02 Subcutaneous implants based on nomegestrol derivatives MY109207A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI93002555A MY109207A (en) 1993-12-02 1993-12-02 Subcutaneous implants based on nomegestrol derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI93002555A MY109207A (en) 1993-12-02 1993-12-02 Subcutaneous implants based on nomegestrol derivatives

Publications (1)

Publication Number Publication Date
MY109207A true MY109207A (en) 1996-12-31

Family

ID=80040100

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93002555A MY109207A (en) 1993-12-02 1993-12-02 Subcutaneous implants based on nomegestrol derivatives

Country Status (1)

Country Link
MY (1) MY109207A (en)

Similar Documents

Publication Publication Date Title
ATE74751T1 (en) OESTRADIOL IMPLANT AND METHOD FOR ITS MANUFACTURE.
EP0388220A3 (en) Compositions for the sustained release of chlorhexidine
IL127510A0 (en) A therapeutic conjugate
MXPA02004671A (en) Interferon gamma conjugates.
EP0276317A4 (en) Gamma-l-glutamyl-l-cysteine ethyl ester and drug containing it as effective ingredient.
EP1125577A3 (en) Liquid drug delivery compositions
WO1996025947A3 (en) Induction of e-selectin for targetting therapeutic agents
IL87885A (en) Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors
HK1040623A1 (en) The use of fumaric acid derivatives in transplantation medicine.
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
IE882727L (en) Sustained release pharmaceutical compositions
EP1093819A3 (en) Compounds and compositions for delivering active agents
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
RU94026906A (en) NEW COMPOSITIONS IN THE FORM OF SCRATCHES IN PLANTS BASED ON NORMEGESTROL DERIVATIVES, METHOD OF THEIR PREPARATION AND APPLICATION
CA2069483A1 (en) Steroid sulphatase inhibitors
AU2740797A (en) Androstene derivatives
EP0426368A3 (en) Compositions containing derivatives of chitin for preventing adhesion
CA2284774A1 (en) Theobromine antitussive compositions
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
ECSP930986A (en) NEW COMPOSITIONS BASED ON NOMEGESTROL DERIVATIVES AND THE PROCESSES FOR ITS PRODUCTION
YU32402A (en) Interferon gamma conjugates
EP0369216A3 (en) Pharmaceutical preparation based on ester derivatives of hecogenine, and their use in treating benign prostatic hyperplasia
MY109207A (en) Subcutaneous implants based on nomegestrol derivatives
ATE181324T1 (en) SECO-D STEROIDS ACTIVE IN THE CARDIOVASCULAR SYSTEM AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
EP1084704A4 (en) Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia